Abstract | OBJECTIVES: MATERIALS AND METHODS: RESULTS: Of 36 expanded-criteria patients, 11 were children and 25 were adults. Sixteen patients (4 pediatric, 12 adult) were within our expanded criteria both radiologically and pathologically before transplant. The other 20 patients (7 pediatric, 13 adult) were within Milan criteria radiologically before transplant; however, after liver transplant, when pathologic specimens were evaluated, patients were found to be within our center's expanded criteria. During follow-up, 9/36 patients (25%) had hepatocellular carcinoma recurrence. In pediatric patients, 5-year and 10-year survival rates were 90%; in adults, 5-year survival was 58.7% and 10-year survival was 49.7%. Overall 5-year and 10-year survival rates were 71.7% and 62.7%. CONCLUSIONS:
|
Authors | Mehmet Haberal, Aydıncan Akdur, Gökhan Moray, Gülnaz Arslan, Figen Özçay, Haldun Selçuk, Handan Özdemir |
Journal | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
(Exp Clin Transplant)
Vol. 15
Issue Suppl 2
Pg. 55-58
(Mar 2017)
ISSN: 2146-8427 [Electronic] Turkey |
PMID | 28302000
(Publication Type: Journal Article)
|
Topics |
- Adolescent
- Adult
- Carcinoma, Hepatocellular
(mortality, secondary, surgery)
- Child
- Decision Support Techniques
- Disease Progression
- Disease-Free Survival
- Female
- Humans
- Infant
- Liver Neoplasms
(mortality, pathology, surgery)
- Liver Transplantation
(adverse effects, mortality)
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Patient Selection
- Predictive Value of Tests
- Retrospective Studies
- Risk Factors
- Survival Analysis
- Time Factors
- Treatment Outcome
- Turkey
|